ArticleJournal of virology2022

Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines.

Cong Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.